Dare Bioscience, Inc. — Director's Dealing 2018

Jun 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2018-06-11

Reporting Person: HAWLEY ROGER (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-11	Common stock	P	140000	$1.4527	Acquired	140000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	490411	Indirect

Footnotes

F1: The price reported is a weighted average. This transaction was executed in multiple trades at prices ranging from $1.385 to $1.48. The reporting person undertakes to provide full information regarding the number of shares and prices at which the trades were effected upon request to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission.